Silence Therapeutics (SLN)
(Delayed Data from NSDQ)
$22.64 USD
+0.62 (2.82%)
Updated Apr 19, 2024 03:59 PM ET
After-Market: $22.74 +0.10 (0.44%) 5:34 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/21/2024
Time: -- |
3/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Silence Therapeutics (SLN) reported earnings of -$0.47 per share, missing the Zacks Consensus Estimate of -$0.25 per share. This reflects a negative earnings surprise of 88.00%. Look out for SLN's next earnings release expected on May 21, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 34.29%.
Earnings History
Price & Consensus
Zacks News for SLN
MediWound (MDWD) Moves 7.1% Higher: Will This Strength Last?
SLN: What are Zacks experts saying now?
Zacks Private Portfolio Services